Pulished Date August, 2019
ID: 7150
Share on
Share on

Asia Pacific Parkinson’s Disease Treatment Market Research Report – Segmented By Drug Class, Distribution Channel, Patient Care Setting and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends, Growth and Forecast | 2019 – 2024

Pulished: August, 2019
ID: 7150
Pages: 145

APAC Parkinson’s Disease Treatment Market Size & Growth (2019 - 2024)

The size of the Asia Pacific Parkinson’s Disease Treatment Market was worth USD 1.04 billion in 2018 and estimated to be growing at a CAGR of 6.79%, to reach USD 1.44 billion by 2023.

The continually increasing number of aging people and increased prevalence of Parkinson's disease are the major factors that are boosting the demand of the in Asia Pacific Parkinson's disease treatment market. The development of innovative and novel treatment methods and increasing popularity for minimally invasive surgeries among the people are propelling the growth of the Asia Pacific Parkinson's disease treatment market. The increasing awareness among the people regarding healthcare is also boosting up the growth rate of Parkinson's disease treatment market in the Asia Pacific. The availability of key market players and an increasing number of manufacturers are also contributing to the growth of the APAC Parkinson's disease treatment market.  

An increasing account of the geriatric population and continuously growing patient base are likely to boost the demand for Parkinson's treatments and expand growth opportunities for the stakeholders in the APAC market. Increasing focus on the R&D activities by the private and public organizations for developing novel and innovative treatment methods owing to immense advancements in healthcare are expected to be creating more growth opportunities for the market over the forecast period. Emerging economies of the developed and developing countries such as India, China, Japan and others in the Asia Pacific are expected to create lucrative opportunities for the market players in the region during the forecast period. Patent expiration of many prominent drugs is foreseen to create lucrative opportunities for the key players in the Asia Pacific Parkinson's disease treatment market.

Stringent regulatory rules and policies are the significant challenges to the growth rate of Parkinson's disease treatment market in this area. Unfavorable reimbursement policies are limiting the growth of Asia Pacific Parkinson's disease treatment market. The availability of alternative treatments is a major challenge for the growth of the Asia Pacific Parkinson's disease treatment market and is expected to restrain the market during the forecast period.

This research report is segmented and sub-segmented into the following categories:

  • By Drug Class: Dopamine Receptor Antagonists (Pramipexole, Ropinirole, Apomorphine and  Rotigotine), Mono Amine Oxidase Inhibitors (Selegiline and Rasagiline), Carbidopa, Anticholinergics and Other Drug Classes
  • By Distribution Channels: Retailer Pharmacies, Hospital Pharmacies and Online Pharmacies
  • By Patient Care Setting: Clinics and Hospitals 
  • By Country: India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, Asia Pacific region is expected to have the fastest growth rate during the forecast period, owing to the huge population base in the region.

Key market participants leading the APAC Parkinson’s Disease Treatment Market profiled in this report are Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany), Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Dopamine Receptor Antagonists   

                                                5.1.1.1 Pramipexole

                                                5.1.1.2 Ropinirole

                                                5.1.1.3 Apomorphine

                                                5.1.1.4 Rotigotine

                                5.1.2 Mono Amine Oxidase Inhibitors    

                                                5.1.2.1 Selegiline

                                                5.1.2.2 Rasagiline

                                5.1.3 Carbidopa

                                5.1.4 Anticholinergics    

                                5.1.5 Other Drug Classes              

                                5.1.6  Y-o-Y Growth Analysis, By Drug Class          

                                5.1.7  Market Attractiveness Analysis, By Drug Class        

                                5.1.8  Market Share Analysis, By Drug Class         

                5.2 Distribution Channel                               

                                5.2.1 Retailer Pharmacies            

                                5.2.2 Hospital Pharmacies            

                                5.2.3 Online Pharmacies               

                                5.2.4 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.2.5 Market Attractiveness Analysis, By Distribution Channel    

                                5.2.6 Market Share Analysis, By Distribution Channel      

                5.3 Patient Care Setting                

                                5.3.1 Clinics        

                                5.3.2 Hospitals  

                                5.3.3 Y-o-Y Growth Analysis, By Patient Care Setting       

                                5.3.4  Market Attractiveness Analysis, By Patient Care Setting    

                                5.3.5  Market Share Analysis, By Patient Care Setting      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Drug Class

                                                6.1.3.2 By Distribution Channel

                                                6.1.3.3 By Patient Care Setting

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Drug Class

                                                6.1.4.2 By Distribution Channel

                                                6.1.4.3 By Patient Care Setting

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Drug Class

                                                6.1.5.2 By Distribution Channel

                                                6.1.5.3 By Patient Care Setting

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Teva                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis AG                                

                8.3 GSK                                

                8.4 AbbVie                         

                8.5 Merck                           

                8.6 Boehringer Ingelheim                            

                8.7 Impax Laboratories                 

                8.8 Lundbeck                    

                8.9 Sun Pharma                                

                8.10 Wockhardt                               

                8.11 UCB                             

                8.12 Valeant Pharmaceuticals                    

                8.13 Acadia                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of By Drug Class type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  2. Asia Pacific Dopamine Receptor Antagonists Market By Region, From 2018-2023( USD Million )
  3. Asia Pacific Mono Amine Oxidase Inhibitors Market By Region, From 2018-2023( USD Million )
  4. Asia Pacific Carbidopa Market By Region, From 2018-2023( USD Million )
  5. Asia Pacific Anticholinergics  Market By Region, From 2018-2023( USD Million )
  6. Asia Pacific Other Drug Classes Market By Region, From 2018-2023( USD Million )
  7. Asia Pacific Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  8. Asia Pacific Retailer Pharmacies Market By Region, From 2018-2023( USD Million )
  9. Asia Pacific Hospital Pharmacies  Market By Region, From 2018-2023( USD Million )
  10. Asia Pacific Online Pharmacies Market By Region, From 2018-2023( USD Million )
  11. Asia Pacific Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )
  12. Asia Pacific Clinics  Market By Region, From 2018-2023( USD Million )
  13. Asia Pacific Hospitals Market By Region, From 2018-2023( USD Million )
  14. Japan Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  15. Japan Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  16. Japan Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )
  17. China Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  18. China Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  19. China Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )
  20. India Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  21. India Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  22. India Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )
  23. Australia Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  24. Australia Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  25. Australia Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )
  26. South Korea Parkinson’s Disease Treatment Market By Drug Class , From 2018-2023( USD Million )
  27. South Korea Parkinson’s Disease Treatment Market By Distribution Channel , From 2018-2023( USD Million )
  28. South Korea Parkinson’s Disease Treatment Market By Patient Care Setting, From 2018-2023( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample